|  | No UTI (N=223) | Overt UTI (N=33) | Pvalue†| |
---|---|---|---|---|---|
 |  | Group AUTI- (N=151) | Group BUTI- (N=72) |  |  |
Age* |  | 47.8 ±13.5 | 47.2 ± 11.3 | 51.2 ± 11.8 | NS |
Female | number (%) | 63 (41.7) | 39 (54.2) | 21 (63.6) | 0.04 |
F/U Duration | Months | 51.0 ± 40.3 | 86.2 ± 37.5 | 83.1 ± 43.3 | <0.001 |
HTN (initial) | number (%) | 90 (59.6) | 51 (70.8) | 26 (78.8) | NS |
Stone (initial) | number (%) | 22 (14.6) | 12 (16.7) | 6 (18.2) | NS |
Initial eGFR‡ | ml/min/1.73m2 | 93.4 ± 26.7 | 89.2 ± 33.0 | 84.7 ± 30.8 | NS |
Final eGFR‡ | ml/min/1.73m2 | 87.6 ± 30.1 | 64.9 ± 38.1 | 57.6 ± 35.2 | <0.001 |
ΔeGFR‡ | ml/min/1.73m2/year | -0.9 ± 5.7 | -2.6 ± 4.4 | -3.6 ± 5.6 | 0.009 |
ESRD | number (%) | 5 (3.3) | 11 (15.3) | 6 (18.2) | 0.001 |